Balloon Tamponade in the Management of Postpartum Haemorrhage: a Review

Total Page:16

File Type:pdf, Size:1020Kb

Balloon Tamponade in the Management of Postpartum Haemorrhage: a Review DOI: 10.1111/j.1471-0528.2009.02113.x Review article www.blackwellpublishing.com/bjog Balloon tamponade in the management of postpartum haemorrhage: a review C Georgioua,b a Graduate School of Medicine, University of Wollongong, Wollongong, New South Wales, Australia b Wollongong Hospital, Department of Obstetrics and Gynaecology, Illawarra, New South Wales, Australia Correspondence: Dr C Georgiou, The Wollongong Hospital Academic Suite, Wollongong Hospital, Block C, Level 8, Crown Street, Wollongong, NSW 2500, Australia. Email [email protected] Accepted 31 December 2008. Obstetric haemorrhage is a significant contributor to worldwide available including the Bakri, Foley, Sengstaken–Blakemore, Rusch maternal morbidity and mortality. Guidelines for the management and condom catheter. This paper reviews these uterine tamponade of postpartum haemorrhage (PPH) involve a stepwise escalation of technologies in the management of PPH. pharmacological and eventual surgical approaches. The method of Keywords Balloon tamponade, intrauterine, management, post- uterine tamponade using balloons has recently been added to the partum haemorrhage, review. armamentarium for managing PPH. There are various balloons Please cite this paper as: Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 2009;116:748–757. Background Uterine tamponade Obstetric haemorrhage is a significant contributor to world- One of the earliest methods of achieving a tamponade effect wide maternal morbidity and mortality.1,2 In Australia and to control PPH was by uterine packing.15 the UK, haemorrhage features within the top four causes of The possibilities of trauma, infection and ineffective pack- direct maternal death as reported in the latest triennial ing resulting in concealed bleeding together with the reports.3,4 increasing effective pharmacological agents to treat uterine Guidelines for the management of postpartum haemor- atony such as ergometrine and syntocinon resulted in a grad- rhage (PPH) involve a stepwise approach including the exclu- ual reluctance in use.16 Despite the declining popularity, in sion of retained products and genital tract trauma. Uterine units where uterine packing was commonly employed, data atony, which is the most common cause,5 is dealt with uterine suggested that it was effective.17,18 In one series of 163 cases, rubbing and various uterotonic agents such as oxytocin, ergo- 158 (97%) of these resulted in ‘immediate control of metrine, misoprostol and prostaglandin F2a (PGF2a).3,6–8 bleeding’.19 If these attempts prove to be unsuccessful and the woman is Sterile gauze was invariably used for uterine packing, but not already having a caesarean section, a laparotomy is con- more recently, balloon technology has been used to tampo- sidered. During this time, various surgical interventions may nade the postpartum uterus to control haemorrhage. This be used. These include internal iliac artery ligation, uterine involves inserting a rubber or silicone balloon into the uterine compression sutures and peripartum hysterectomy to control cavity and inflating the balloon with normal saline. The the life-threatening haemorrhage.9–11 balloons in descending order of relative cost include the Recently, uterine balloon tamponade has been added to Sengstaken–Blakemore tube, the Bakri balloon, the Rusch this armamentarium in the management of PPH.7,12–14 The balloon, Foley catheters and the condom catheter balloon purpose of this paper was to review the various uterine tam- (Tables 1 and 2, Figures 1 and 2). ponade technologies currently available for the management Currently, the intrauterine balloon is believed to act by of PPH. exerting in inward-to-outward pressure ‘that is greater than 748 ª 2009 The Authors Journal compilation ª RCOG 2009 BJOG An International Journal of Obstetrics and Gynaecology Balloon tamponade in the management of postpartum haemorrhage the systemic arterial pressure’ to prevent continual bleeding.35 Foley catheters, filled to 30–50, 80 and 110 ml, respectively, More recently, an alternative mechanism of action has been were used in postpartum haemorrhage following unsuccessful proposed, which involves the hydrostatic pressure effect of the use of pharmacological agents and despite uterine curette.34 balloon on the uterine arteries.28 Many of these balloons have previously been used to con- Sengstaken–Blakemore tube trol haemorrhage at other anatomical sites, including the bladder36 and oesophagus,37 as well as to control PPH from The volume of a postpartum uterus was considered too large vaginal lacerations.38 for an effective tamponade to be achieved by using a 30-ml 45 Furthermore, these same technologies have been used in Foley catheter balloon as used in gynaecological procedures. gynaecological conditions in which bleeding is problematic, for Therefore, the Sengstaken–Blakemore two-balloon tube, orig- example following first- and second-trimester termination of inally designed for the management of bleeding oesophageal 37 pregnancy,20,39 cervical pregnancy,40–44 knifeconebiopsy,33 laser varices, was used. The distal, gastric balloon was filled with ablation of the endometrium, dysfunctional uterine bleeding,45 300 ml of normal saline to control uterine atony following 23 multiple vaginal lacerations46 and bleeding from a cervical stump vaginal delivery and manual removal of the placenta following a post-caesarean section subtotal hysterectomy.47 (Table 1, Figures 1 and 2). Subsequently, the proximal oesophageal balloon of the Seng- staken–Blakemore tube was used24 (Table 1, Figures 1 and 2). Bakri balloon Bakri first published the concept of intrauterine balloon tech- Rusch balloon nology in the management of haemorrhage secondary to pla- The greater cost of the Sengstaken–Blakemore tube in com- centa praevia–accreta during caesarean section with or parison to the Bakri balloon and the premise that the uterine 48 without bilateral hypogastric arterial ligation. Multiple uri- cavity requires a balloon capable of being insufflated to a large nary Foley catheters were inserted together with a ‘haemostatic volume resulted in the use of the urological Rusch balloon29 substance’ applied to the oozing inner surface of the lower (Figures 1 and 2). This balloon is reported having an insuf- uterine segment to function as a ‘haemostatic cushion’. The flation capacity of 1500 ml.30 uterine incision site was then closed, and each of the balloons The Rusch balloon was first used for continual uterine 3 was inflated with 35–75 cm of saline or water. Gentle traction bleeding after removal of a morbidly adherent placenta and was then applied to obtain a continuous tamponade effect, an adherent succenturiate lobe. In the former case, balloon and the vagina was packed. application followed a failed Sengstaken–Blakemore tube The catheters were then tied together, and an examination application and unilateral uterine artery embolisation. The glove or plastic bag was used for the collection and measure- other uterine artery being inaccessible for embolisation. In ment of blood loss. This was suggested to help prevent blood both cases, the Rusch urological balloon was inflated with collection inside the uterine cavity and provide an accurate 400–500 ml of warm saline and removed after 24 hours fol- estimation of bleeding. lowing deflation at a rate of 20 ml/hour29 (Table 1). Later, a ‘balloon device for controlling capillary/venous bleed- ing and surface oozing’ in cases of ‘placenta praevia with variable Condom catheters degrees of accretism’ was described49 (Figures 1 and 2). The now termed Bakri ‘SOS’ (Surgical Obstetric Silicone) balloon was The principle of a fluid-filled structure exerting a tamponade described with a capacity of up to 500 ml of saline achieving a effect to stop bleeding36,37 has also been exemplified by the use ‘pressure and tamponade effect to control the bleeding state’. of condom catheters in the management of PPH. This ‘Sayeba’s A subsequent article described the successful use of the method of PPH control’ was used in a prospective study of 23 Bakri (SOS) balloon in four women with PPH resulting from cases31,32,50 (Figures 1 and 2). A latex condom was inserted into a low-lying placenta/placenta praevia20 (Table 1). the uterus by means of a size 16 rubber catheter and inflated with 250–300 ml of isotonic saline until the bleeding was con- Foley catheters trolled. The condom catheter was then removed after 24–48 hours (Table 1). Both single and multiple Foley catheters have been used in the Two further cases using this condom catheter were management of PPH48 (Table 1, Figures 1 and 2). In one case, described in the management of PPH in women with despite uterine curette and failed uterine packing using dry impaired coagulation32 (Table 1). In the first case, a condom sterile gauze, five Foley catheters were inserted into the uter- tied with silk to the tip 3–4 cm of the Foley catheter was ine cavity.33 They were inflated with 80 ml normal saline to placed in uterus. The condom was inflated (250 ml saline) achieve haemostasis and subsequently removed after 36 hours until bleeding was reduced. The proximal end of catheter was without further bleeding (Table 1). Three other cases of single ligated to prevent backflow, and the vagina was packed with ª 2009 The Authors Journal compilation ª RCOG 2009 BJOG An International Journal of Obstetrics and Gynaecology 749 Georgiou Table 1. Balloon tamponade devices Balloon Number Timing of use Cause of PPH Use of Failed surgical Additional surgical
Recommended publications
  • Course of Gynecology
    RWAMAGANA SCHOOL OF NURSING AND MIDWIFERY PO.BOX 2 RWAMAGANA COURSE OF GYNECOLOGY 2nd year nursing &midwifery FACILITATOR: MUSENGIMANA 1 INFORMATIONS RELATED TO THE COURSE 1. COURSE DESCRIPTION Throughout this course different variations of structure and functions of female reproductive system will be discussed, it is important for a nurse and midwife to be familiar with various terminologies used in gynecology. Common problems encountered in gynecology will be discussed in detail in terms of prevention of risk and treatment. 2. BACKGROUND & PURPOSE OF COURSE The course aim is to enable the learner to understand and manage problems which can occur in female. 3. Course objectives At the end of this course, student will be able to: • To define gynecological conditions and diseases • To identify their etiologies • To explain their pathogenesis • To enumerate principal signs and symptoms of gynecological problems • To diagnose gynecology diseases • To manage client with gynecological diseases 4. TEACHING/LEARNING METHODS Lecturing Group discussions Presentations Case studies 5. REFERENCES Coad. (2008), Anatomy and physiology for midwives, 2nd edition, Churchill Livingstone, 2 London, U.K Dictionary of nursing (2007), 2nd edition, Black publisher ltd, London Elisabeth A Gangar (2001) Gynecological nursing, a practical guide, Churchill Livingstone, London, U.K Ellis Q. Y .Marcia S.D (2004) Women’s health, a primary care clinical guide, 3rd edition. Pearson Education, Inc. Fraser D& Cooper M. (2003).Myles textbook for midwives, Churchill Livingstone, London, U.K Kerri D S and Frances E.L (2006) Women’s gynecologic health, Jones and Bartlett, USA UNIT I. INTRODUCTION 3 I.0.DEFINITION 1. Gynecology The branch of medicine particularly concerned with the health of the female organs of reproduction and diseases thereof.
    [Show full text]
  • Journal of the Faculty of Medicine Rev
    Journal of the Faculty of Medicine Rev. Fac. Med. 2018 Año 70 Vol. 66 No. 2 Epidemiological characterization of ophidian accidents in a Colombian ISSN 0120-0011 tertiary referral hospital. Retrospective study 2004 - 2014 e-ISSN 2357-3848 http://www.revistas.unal.edu.co/index.php/revfacmed Journal of the Faculty of Medicine Rev. Fac. �Med. 2018 Año 70, Vol. 66, No. 2 Faculty of Medicine Editorial Committee Javier Eslava Schmalbach. MD.MSc.PhD. Universidad Nacional de Colombia. Colombia. Franklin Escobar Córdoba. MD.MPF.PhD. Universidad Nacional de Colombia. Colombia. Lisieux Elaine de Borba Telles MD. MPF. PhD. Universidade Federal do Rio Grande do Sul. Brazil. Adelaida Restrepo PhD. Arizona State University. USA. Eduardo De La Peña de Torres PhD. Consejo Superior de Investigaciones Científicas. España. Fernando Sánchez-Santed MD. Universidad de Almería. España. Gustavo C. Román MD. University of Texas at San Antonio. USA. Jorge E. Tolosa MD.MSCE. Oregon Health & Science University. USA. Jorge Óscar Folino MD. MPF. PhD. Universidad Nacional de La Plata. Argentina. Julio A. Chalela MD. Medical University of South Carolina. USA. Sergio Javier Villaseñor Bayardo MD. PhD. Universidad de Guadalajara. México. Cecilia Algarin MD., Universidad de Chile. Lilia María Sánchez MD., Université de Montréal. Claudia Rosario Portilla Ramírez PhD.(c)., Universidad de Barcelona. Marco Tulio de Mello MD. PhD. , Universidade Federal de Sao Paulo. Dalva Poyares MD. PhD., Universidade Federal de São Paulo. Marcos German Mora González, PhD., Universidad de Chile Eduardo José Pedrero-Pérez, MSc. PhD., Instituto de Adicciones, Madrid Salud. María Angélica Martinez-Tagle MSc. PhD., Universidad de Chile. Emilia Chirveches-Pérez, PhD., Consorci Hospitalari de Vic María Dolores Gil Llario, PhD., Universitat de València Fernando Jaén Águila, MD, MSc., Hospital Virgen de las Nieves, Granada.
    [Show full text]
  • Efficacy and Complications of Emergent Transcatheter Arterial Embolization for the Management of Intractable Uterine Bleeding
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE Dokkyo Journal of Medical Sciences 47(1)(2020)47(1):15〜 25,2020The efficacy and complications of UAE for intractable uterine bleeding 15 Original Efficacy and Complications of Emergent Transcatheter Arterial Embolization for the Management of Intractable Uterine Bleeding Emi Motegi 1), Kiyoshi Hasegawa 1), Shoko Ochiai 1), Mariko Watanabe 1), Kazumi Tada 1), Susumu Miyashita 1), Satoshi Obayashi 1), Kensuke Inamura 2), Hiroaki Ikeda 2), Yasukazu Shioyama 2), Yasushi Kaji 2), Ichio Fukasawa 1) 1 Department of Obstetrics and Gynecology, Dokkyo Medical University, Mibu, Tochigi, Japan 2 Department of Radiology, Dokkyo Medical University, Mibu, Tochigi, Japan SUMMARY Objective:Transcatheter arterial embolization(TAE), including uterine artery embolization(UAE), is effective for the management of obstetric and gynecologic hemorrhage. Some adverse effects have been reported with TAE, such as amenorrhea, endometrial trauma, and subsequent infertility. Herein we report the efficacy and complications of emergent TAE for the management of severe intractable uterine bleeding at our institute. Methods:From 2010 to 2019, thirty-eight patients underwent emergent TAE for intractable uterine bleeding. We evaluated the efficacy and complications of TAE, including a change in menstruation, fertility, and pregnancy outcomes in perinatal patients(group A;n=23), and in patients with gynecologic hemor- rhage(group B;n=15). Results:In group A, 7 cases of retained placenta, 4 cases of postpartum hemorrhage, 2 cases of placenta accrete, 2 cases of uterine artery pseudoaneurysm, 2 cases of cervical pregnancy, 1 case of cesarean scar pregnancy, and 5 cases of unexplained hemorrhage were included.
    [Show full text]
  • “See & Treat Hysteroscopy in Daily Practice”
    UNIVERSITY OF NAPLES “FEDERICO II” FACULTY OF MEDICINE DEPARTMENT OF GYNAECOLOGY AND OBSTETRICS, AND PATHOPHYSIOLOGY OF HUMAN REPRODUCTION “RIPRODUZIONE, SVILUPPO E ACCRESCIMENTO DELL’UOMO” PHD THESIS XXI CICLO Course coordinator : Prof. Claudio Pignata Tutor: Prof. Carmine Nappi “SEE & TREAT HYSTEROSCOPY IN DAILY PRACTICE” Candidate Attilio Di Spiezio Sardo Academic course 2005- 2008 INDEX Chapter 1: Historical background Pag. 1 Chapter 2: Equipment and Office Set Up Pag. 11 Chapter 3: Feasibility and Adoption Pag. 23 • Vaginoscopic approach Pag. 26 - M. Sharma, A. Taylor, A. Di Spiezio Sardo, L. Buck, G. Mastrogamvrakis, I. Kosmas, P. Tsirkas, A. Magos. Outpatient hysteroscopy: traditional versus the ‘no-touch’ technique. BJOG. 2005; 112: 963–967 Chapter 4: Traditional techniques of “See and treat” hysteroscopy (1995- 2006) Pag. 31 • Endometrial biopsy Pag. 31 • Polypectomy Pag. 33 • Myomectomy Pag. 34 - A. Di Spiezio Sardo, I. Mazzon, S. Bramante, S. Bettocchi, G. Bifulco, M. Guida, C. Nappi Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update, 2007: 1–19 - S. Bettocchi, C. Siristatidis, G. Pontrelli, A. Di Spiezio Sardo, O. Ceci, L. Selvaggi. The destiny of myomas: should we treat small submucous myomas in women of reproductive age. Fertil Steril 2007 • Metroplasty Pag. 35 • Intrauterine adhesiolysis Pag. 35 • Cervical adhesiolisys Pag. 36 • Hysteroscopic sterilization Pag. 37 Chapter 5: New frontiers of “see and treat” hysteroscopy ( 2006- 2008) Pag. 38 • Treatment of vaginal polyps Pag. 39 - M. Guida, A. Di Spiezio Sardo, C. Mignogna , S. Bettocchi , C. Nappi. Vaginal fibro-epithelial polyp as cause of postmenopausal bleeding: office hysteroscopic treatment. Gynecol Surg 2008; 5: 69–70 - A.
    [Show full text]
  • Iatrogenic Uterine Vascular Lesions: Diagnosis with Color Doppler Ultrasound and Treatment with Transcatheter Arterial Embolization "A Case Report"
    Available online at www.ijmrhs.com International Journal of Medical Research & ISSN No: 2319-5886 Health Sciences, 2016, 5, 8:288-292 Iatrogenic uterine vascular lesions: Diagnosis with color doppler ultrasound and treatment with transcatheter arterial embolization "a case report" Mohammad Momen Gharibvand 1, Mohammadreza Jahanshahi 2,Azim Motamedfar 3, Kobra Shojaei 4, Najmieh Saadati 5, Azar Ahmadzadeh 6, Mohammad davoodi 7 and Aliakbar Sahraeizadeh 8* 1M.D. Assistant Professor of Radiology, Department of Radiology, school of medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran 2M.D. Diagnostic Radiology Resident, Department of Radiology, school of medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran 3M.D.Assistant Professor of Radiology, Department of Radiology, school of medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran 4M.D. Assistant Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, school of medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran 5M.D.Assistant Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, school of medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran 6M.D.Assistant Professor of Obstetrics and Gynecology, Department of Obstetrics and Gynecology, school of medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran 7 M.D. Associate professor of Radiology, Department of Radiology, school of medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran 8M.D. Diagnostic Radiology resident, Department of Radiology, school of medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran *Corresponding Author Email:[email protected] _____________________________________________________________________________________________ ABSTRACT Uterine vascular lesions are considered as a rare complication of gynecologic and obstetric procedures.
    [Show full text]
  • PPH 2Nd Edn #23.Vp
    38 Non-pneumatic Anti-Shock Garments: Clinical Trials and Results S. Miller, J. L. Morris, M. M. F. Fathalla, O. Ojengbede, M. Mourad-Youssif and P. Hensleigh (deceased) INTRODUCTION resembles the lower part of a wet suit. The NASG, manufactured by the Zoex Company, received a The International Federation of Gynecology and United States Food and Drug Administration (FDA) Obstetrics (FIGO)/International Confederation of 510(k) medical device regulations number (FDA device Midwives (ICM) recommendations for active # K904267/A, Regulatory Class: II, January 17, 1991) management of third-stage labor, including uterotonic (Section 510(k) Medical Device Amendment, FDA, prophylaxis with additional uterotonic treatment when Office of Device Evaluation, 1991) and can be necessary, clearly reduce the incidence of severe post- exported to countries outside the United States. The partum hemorrhage (PPH) due to uterine atony1. NASG is designed in horizontal segments, with three Despite this, many women suffer intractable PPH segments for each leg, a segment to be placed over the from atony or other obstetric etiologies, including pelvis, and a segment over the abdomen that contains a genital lacerations, ruptured uterus, ruptured ectopic small, foam compression ball (Figure 1). pregnancies, as well as placenta previa, accreta and Unlike the pneumatic anti-shock garment (PASG), abruption. Multiple blood transfusions are often or medical anti-shock trousers (MAST), both of which required to resuscitate and stabilize these individuals, preceded the development of the NASG, there are no and the institution of hemostasis may require surgical pumps, tubing, or gauges to add either complexity or interventions or procedures only available at tertiary risk of malfunction.
    [Show full text]
  • Surgical Management of Massive Postpartum Hemorrhage with Uterine Atony
    Journal of Gynecology and Women’s Health ISSN 2474-7602 Opinion J Gynecol Women’s Health Volume 5 Issue 1 - May 2017 Copyright © All rights are reserved by Apichart Chittacharoen DOI: 10.19080/JGWH.2017.05.555653 Surgical Management of Massive Postpartum Hemorrhage with Uterine Atony Apichart Chittacharoen* Department of Obstetrics & Gynaecology, Mahidol University, Thailand Submission: May 16, 2017 ; Published: May 30, 2017 *Corresponding author: Apichart Chittacharoen, Department of Obstetrics & Gynaecology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Thailand, Email: Opinion Postpartum hemorrhage (PPH) is an obstetrical emergency Although uterine packing was advocated for treating PPH in that can follow vaginal or cesarean delivery. It is a major cause the past, it fell out of use largely due to concerns of concealed of maternal morbidity, with sequelae such as shock, renal hemorrhage and uterine over distension. In recent years, failure, acute respiratory distress syndrome, co agulopathy, and these concerns. Balloon tamponade using eg. a Foley catheter, however, several modifications of this procedure have allayed of maternal mortality in both high income and low income a Sengstaken-Blakemore tube, Bakri tamponade balloon, Rusch Sheehan’s syndrome [1]. PPH is also one of the top five causes countries, although the absolute risk of death is much lower in hydrostatic balloon has been shown to effectively control the former than the latter (1 in 100,000 versus 1 in 1000 births) postpartum bleeding and may be useful in several settings: uterine [2]. Life-threatening PPH occurs with a frequency of 1 in 1000 atony, retained placental tissue, and placenta accrete [6-12]. The deliveries in the developed world.
    [Show full text]
  • Virtamed Gynos™ Hysteroscopy Module Descriptions
    VirtaMed GynoS™ hysteroscopy Module descriptions VirtaMed AG | Rütistr. 12, 8952 Zurich | Switzerland | [email protected] | www.virtamed.com | Phone: +41 44 500 9690 Table of contents Table of contents .................................................................................................................................................. 1 Essential skills module .......................................................................................................................................... 2 Module description ........................................................................................................................................... 2 SimProctor™ educational guidance .................................................................................................................. 2 Learning objectives ........................................................................................................................................... 2 Instruments ...................................................................................................................................................... 2 Hysteroscopy module ........................................................................................................................................... 4 Module description ........................................................................................................................................... 4 Learning objectives ..........................................................................................................................................
    [Show full text]
  • Us 2018 / 0305689 A1
    US 20180305689A1 ( 19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2018 /0305689 A1 Sætrom et al. ( 43 ) Pub . Date: Oct. 25 , 2018 ( 54 ) SARNA COMPOSITIONS AND METHODS OF plication No . 62 /150 , 895 , filed on Apr. 22 , 2015 , USE provisional application No . 62/ 150 ,904 , filed on Apr. 22 , 2015 , provisional application No. 62 / 150 , 908 , (71 ) Applicant: MINA THERAPEUTICS LIMITED , filed on Apr. 22 , 2015 , provisional application No. LONDON (GB ) 62 / 150 , 900 , filed on Apr. 22 , 2015 . (72 ) Inventors : Pål Sætrom , Trondheim (NO ) ; Endre Publication Classification Bakken Stovner , Trondheim (NO ) (51 ) Int . CI. C12N 15 / 113 (2006 .01 ) (21 ) Appl. No. : 15 /568 , 046 (52 ) U . S . CI. (22 ) PCT Filed : Apr. 21 , 2016 CPC .. .. .. C12N 15 / 113 ( 2013 .01 ) ; C12N 2310 / 34 ( 2013. 01 ) ; C12N 2310 /14 (2013 . 01 ) ; C12N ( 86 ) PCT No .: PCT/ GB2016 /051116 2310 / 11 (2013 .01 ) $ 371 ( c ) ( 1 ) , ( 2 ) Date : Oct . 20 , 2017 (57 ) ABSTRACT The invention relates to oligonucleotides , e . g . , saRNAS Related U . S . Application Data useful in upregulating the expression of a target gene and (60 ) Provisional application No . 62 / 150 ,892 , filed on Apr. therapeutic compositions comprising such oligonucleotides . 22 , 2015 , provisional application No . 62 / 150 ,893 , Methods of using the oligonucleotides and the therapeutic filed on Apr. 22 , 2015 , provisional application No . compositions are also provided . 62 / 150 ,897 , filed on Apr. 22 , 2015 , provisional ap Specification includes a Sequence Listing . SARNA sense strand (Fessenger 3 ' SARNA antisense strand (Guide ) Mathew, Si Target antisense RNA transcript, e . g . NAT Target Coding strand Gene Transcription start site ( T55 ) TY{ { ? ? Targeted Target transcript , e .
    [Show full text]
  • Virtamed Gynos™ Module Descriptions
    VirtaMed GynoS™ Module descriptions Table of contents Essential skills module .......................................................................................................................................... 2 Hysteroscopy module ........................................................................................................................................... 4 Advanced hysteroscopy module ......................................................................................................................... 11 Intrauterine device (IUD) placement module ..................................................................................................... 13 ASRM Embryo transfer module .......................................................................................................................... 15 Transvaginal obstetric ultrasond module ........................................................................................................... 19 If you have questions regarding this document, please contact VirtaMed for technical support: +41 44 542 91 10 [email protected] VirtaMed AG | Rütistr. 12, 8952 Zurich | Switzerland | [email protected] | www.virtamed.com | Phone: +41 44 500 9690 © VirtaMed AG 2019. All rights reserved. v.1903 1 Essential skills module First steps in diagnostic and operative hysteroscopy Module description The HystSim™ essential skills module is a complete curriculum designed for structured integration of hysteroscopy training in OB/GYN residency programs. It contains eight different
    [Show full text]
  • Hypogastric Artery Embolization
    Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 607e608 Contents lists available at ScienceDirect Taiwanese Journal of Obstetrics & Gynecology journal homepage: www.tjog-online.com Research Letter Salvage therapy in acute life-threatening vaginal bleeding of cervical cancer: Hypogastric artery embolization * Sema Süzen Çaypınar , Hakan Güraslan, Baki S¸ entürk, Hüseyin Cengiz, Levent Yas¸ar Department of Gynecology and Obstetrics, Bakirkoy Dr. Sadi Konuk Teaching and Research Hospital, Istanbul, Turkey article info Article history: bleeding during chemoradiotherapy. However, 2 months ago, the Accepted 9 January 2015 patient was admitted to our emergency room with massive cervical bleeding without blood clotting. On physical examination, blood pressure was 60/30 mmHg, and heart rate was 130 beats per minute. Laboratory tests showed severe anemia (hemoglobin, Dear Editor, 5 mg/dL). During this period, the patient underwent transfusion with a total of five units of blood to correct anemia. Bleeding did not Cervical cancer is the second leading cause of death among stop with the application of vaginal tamponade in combination women in the world [1]. Eighty percent of these deaths occur in with hemostatic agents. Also, severe pelvic pain occurred due to developing countries with low socioeconomic status [2]. It is the local tumor pressure with tamponade. Pain control could not be ninth most common cancer among females in Turkey, with an achieved by the anesthesiologist. Considering the increased incidence rate of 4.76 per 1000 [3], and it is a well-known fact that bleeding, the patient was planned to undergo laparoscopic ligation the most frequent cause of mortality in terminal-stage cervical of the hypogastric arteries; however, we decided to perform se- cancer cases is bleeding and uremia.
    [Show full text]
  • PPH 2Nd Edn #23.Vp
    54 The Pelvic Pressure Pack and the Uterovaginal Balloon System G. A. Dildy III When pharmacologic and conservative surgical inter- trauma16, pre-eclampsia-induced hepatic rupture17, ventions fail to correct postpartum hemorrhage (PPH), rectal cancer18, gynecologic cancer19 and, more hysterectomy most often becomes the option of last recently, retroperitoneal packing as a part of damage- resort1. Contemporary reports on the incidence of control surgery for trauma-related pelvic fracture obstetric hysterectomy range between 0.29 and 0.77 management20–22. Various packing methods have per 1000 deliveries2–7. Under these circumstances, a been described, such as the ‘bowel bag’19 or packing moderately busy obstetric unit with 4000 deliveries per with dry laparotomy packs23. These methods, how- year may perform as many as three emergency hysterec- ever, require re-laparotomy after initial stabilization to tomies annually. This is especially true for women remove the packing materials. Other reported meth- undergoing multiple repeat cesarean deliveries. Silver ods for packing, albeit not requiring re-laparotomy and colleagues reported in the Maternal–Fetal Medicine but with limited cumulative obstetric experience, Units Network examination of 30,132 women under- include transcutaneous placement of an inflated con- going cesarean delivery, that hysterectomy was required dom over a 22-Fr catheter24 or ribbon gauze within a in 0.65% of first, 0.42% of second, 0.90% of third, Penrose drain25. 2.41% of fourth, 3.49% of fifth, and 8.99% of sixth or In 1926, Logothetopoulos described a pack for the greater number cesarean deliveries8. management of uncontrolled posthysterectomy pelvic A systematic review of 981 cases of emergency bleeding26.
    [Show full text]